directly or indirectly active pharmaceutical ingredient (API), pharmaceutical products or formulations containing Vildagliptin alone or Vildagliptin + Metformin Hydrochloride in comination or Vildagliptin in combination with ... defendant, in the event of manufacture and sale of any Vildagliptin API or infringing pharmaceutical products or formulation containing Vildagliptin alone or Vildagliptin + Metformin Hydrochloride
indirectly dealing in active pharmaceutical ingredient (API), pharmaceutical products or formulations containing Vildagliptin alone or Vildagliptin in combination with any other compound ... defendants, in the event of manufacture and sale of any Vildagliptin API or infringing pharmaceutical products or formulation containing Vildagliptin alone or Vildagliptin with
said notes read
as under:-
"b. Sitagliptin 100mg/Vildagliptin 100mg/Saxagliptin
5mg shall be considered equivalent for L-1 calculation; the
demand of Gliptin ... that in note (b), three drugs
have been mentioned, namely, Sitagliptin, Vildagliptin and Saxagliptin and that
as per the note, these three drugs
offer for sale pharmaceutical products,
compounds or formulations or active ingredients containing Vildagliptin,
that may amount to infringement of the aforesaid patent, the present suit
